Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Morphic Therapeutic
Biotech
How Morphic stayed focused on Lilly to reel in $3.2B buyout
Lilly’s $3.2 billion Morphic buyout is a simple story of two companies gradually closing the gap between their positions before tying the knot.
Nick Paul Taylor
Jul 19, 2024 8:24am
Lilly inks $3.2B Morphic buyout to take on Takeda in IBD
Jul 8, 2024 8:20am
Bayer undergoes leadership shake-up—Chutes & Ladders
Mar 22, 2024 9:30am
Morphic's stock sinks as data on oral Entyvio rival disappoint
Sep 25, 2023 6:00am
Morphic loses another Big Pharma partner as J&J scraps pact
Jan 23, 2023 7:41am
BIO CEO out the door—Chutes & Ladders
Oct 14, 2022 9:30am
